Get started
Author

Anita Hill

Observed names: A Hill, A. Hill
Observed institutions: National Health Service, Leeds General Infirmary, University of Leeds, St George's Hospital, University of Bradford, St George's, University of London, Université Paris Cité, University of Cambridge, Leeds Teaching Hospitals NHS Trust, Leiden University Medical Center, Bradford Royal Infirmary, St James's University Hospital, John Radcliffe Hospital, Centre Hospitalier Universitaire de Bordeaux, Centre Hospitalier Universitaire de Toulouse, University of Oxford, Institut universitaire du cancer de Toulouse Oncopole, Inflazyme (Canada), Alexion Pharmaceuticals (United States), Hôpital Saint-Louis, Centre Hospitalier Universitaire de Rennes, Addenbrooke's Hospital, Bradford Teaching Hospitals NHS Foundation Trust
ORCID: 0009-0002-7203-6443
Observed ORCID: 0009-0002-7203-6443
OpenAlex ID: A5111697105
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
2006 · Peter Hillmen, Neal S. Young, et al. · New England Journal of Medicine · 1,303
PDF
Guidelines for the diagnosis and management of adult aplastic anaemia
2015 · Sally B. Killick, Nick Bown, et al. · British Journal of Haematology · 749
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
2007 · Peter Hillmen, Petra Muus, et al. · Blood · 579
PDF
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
2019 · Ulrich Jäger, Wilma Barcellini, et al. · Blood Reviews · 565
Thrombosis in paroxysmal nocturnal hemoglobinuria
2013 · Anita Hill, Richard J. Kelly, et al. · Blood · 478
Paroxysmal nocturnal haemoglobinuria
2017 · Anita Hill, Amy E. DeZern, et al. · Nature Reviews Disease Primers · 458
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
2022 · Régis Peffault de Latour, Austin Kulasekararaj, et al. · New England Journal of Medicine · 304
PDF
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
2015 · Richard J. Kelly, Britta Höchsmann, et al. · New England Journal of Medicine · 286
PDF
The diagnosis and management of primary autoimmune haemolytic anaemia
2016 · Quentin A. Hill, Robert Stamps, et al. · British Journal of Haematology · 275
PDF
Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria
2005 · Anita Hill, Peter Hillmen, et al. · Blood · 212
Autoimmune hemolytic anemia
2018 · Anita Hill, Quentin A. Hill · Hematology · 189
Novel insights into the treatment of complement-mediated hemolytic anemias
2019 · Sigbjørn Berentsen, Anita Hill, et al. · Therapeutic Advances in Hematology · 165
Guidelines on the management of drug‐induced immune and secondary autoimmune, haemolytic anaemia
2017 · Quentin A. Hill, Robert Stamps, et al. · British Journal of Haematology · 159
PDF
Effect of eculizumab on haemolysis‐associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria
2010 · Anita Hill, Russell P. Rother, et al. · British Journal of Haematology · 158
Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria
2007 · Anita Hill, Stephen J. Richards, et al. · British Journal of Haematology · 139
PDF
Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria
2020 · Robert A. Brodsky, Régis Peffault de Latour, et al. · Haematologica · 128
PDF
Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment
2019 · Quentin A. Hill, Anita Hill, et al. · Blood Advances · 121
Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies
2018 · Alexander Röth, Scott T. Rottinghaus, et al. · Blood Advances · 86
Under‐recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function
2012 · Anita Hill, Robert J. Sapsford, et al. · British Journal of Haematology · 71
PDF
Efficacy of recombinant erythropoietin in autoimmune haemolytic anaemia: a multicentre international study
2020 · Bruno Fattizzo, Marc Michel, et al. · Haematologica · 69
PDF
Protection of erythrocytes from human complement–mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy
2005 · Anita Hill, Simon H. Ridley, et al. · Blood · 53
PDF
Recent advances in the diagnosis, monitoring, and management of patients with paroxysmal nocturnal hemoglobinuria
2007 · Stephen J. Richards, Anita Hill, et al. · Cytometry Part B Clinical Cytometry · 48
PDF
Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria
2020 · John Devin Peipert, Austin G. Kulasekararaj, et al. · PLoS ONE · 47
PDF
Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal hemoglobinuria.
2005 · Anita Hill, Russell P Rother, et al. · PubMed · 44
Survival of patients with hematological malignancy admitted to the intensive care unit: prognostic factors and outcome compared to unselected medical intensive care unit admissions, a parallel group study
2011 · Quentin A. Hill, Richard J. Kelly, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 36
Works count: 69
Citation count: 7,039
H-index: 27
I10-index: 41
Year
Topic
Type